- Public Comps
- Pulsenmore
Pulsenmore Valuation Multiples
Discover revenue and EBITDA valuation multiples for Pulsenmore and similar public comparables like Labo Euromedis, Genomtec, Inspira Technologies, Conavi Medical and more.
Pulsenmore Overview
About Pulsenmore
Pulsenmore Ltd is engaged in developing portable ultrasound devices for home use. Its ultrasound scanner dock's with patients' smartphones to deliver images that can be created anywhere, stored and forwarded for clinical review, or shared in an online consultation.
Founded
N/A
HQ

Employees
63
Website
Financials (FY)
Market Cap
$17M
Valuation Multiples
Start free trialPulsenmore Financials
Pulsenmore reported last fiscal year revenue of $13M and negative EBITDA of ($5M).
In the same fiscal year, Pulsenmore generated $11M in gross profit, ($5M) in EBITDA losses, and had net loss of ($5M).
Pulsenmore P&L
In the most recent fiscal year, Pulsenmore reported revenue of $13M and EBITDA of ($5M).
Pulsenmore is unprofitable as of last fiscal year, with gross margin of 84%, EBITDA margin of (41%), and net margin of (40%).
Financial data powered by Morningstar, Inc.
Pulsenmore Stock Performance
Pulsenmore has current market cap of $17M.
Market Cap Evolution
Pulsenmore's stock price is $2.61.
Pulsenmore share price decreased by 1.0% in the last 30 days, and by 77.0% in the last year.
Pulsenmore has an EPS (earnings per share) of $-0.81.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $17M | -0.7% | -1.0% | -50.9% | -77.0% | $-0.81 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPulsenmore Valuation Multiples
Pulsenmore Financial Valuation Multiples
As of September 4, 2026, Pulsenmore has market cap of $17M.
Pulsenmore has a P/E ratio of (3.2x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Pulsenmore Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Pulsenmore Margins & Growth Rates
In the most recent fiscal year, Pulsenmore reported gross margin of 84%, EBITDA margin of (41%), and net margin of (40%).
Pulsenmore Margins
Pulsenmore Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Pulsenmore Operational KPIs
Pulsenmore's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Pulsenmore Competitors
Pulsenmore competitors include Labo Euromedis, Genomtec, Inspira Technologies, Conavi Medical, CelLBxHealth, Geratherm Medical, Promimic, Scandinavian Real Heart, European Medical Solutions and ViroGates.
Most Pulsenmore public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.1x | - | 6.5x | - | |||
| 2906.2x | - | (8.2x) | - | |||
| 48.0x | 48.0x | (1.3x) | (1.3x) | |||
| 4.4x | 4.3x | (4.9x) | - | |||
| 8.5x | 6.2x | (0.7x) | (1.4x) | |||
| 0.4x | 0.5x | 32.9x | 5.8x | |||
| 3.3x | - | (50.5x) | - | |||
| - | - | (3.3x) | - | |||
This data is available for Pro users. Sign up to see all Pulsenmore competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Pulsenmore
| Where is Pulsenmore headquartered? | Pulsenmore is headquartered in Israel. |
| How many employees does Pulsenmore have? | As of today, Pulsenmore has over 63 employees. |
| Is Pulsenmore publicly listed? | Yes, Pulsenmore is a public company listed on Tel Aviv Stock Exchange. |
| What is the stock symbol of Pulsenmore? | Pulsenmore trades under PLSM ticker. |
| When did Pulsenmore go public? | Pulsenmore went public in 2021. |
| Who are competitors of Pulsenmore? | Pulsenmore main competitors include Labo Euromedis, Genomtec, Inspira Technologies, Conavi Medical, CelLBxHealth, Geratherm Medical, Promimic, Scandinavian Real Heart, European Medical Solutions, ViroGates. |
| What is the current market cap of Pulsenmore? | Pulsenmore's current market cap is $17M. |
| What is the current revenue of Pulsenmore? | Pulsenmore's last fiscal year revenue is $13M. |
| Is Pulsenmore profitable? | No, Pulsenmore is not profitable. |
| How many companies Pulsenmore has acquired to date? | Pulsenmore hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Pulsenmore has invested to date? | Pulsenmore hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Pulsenmore
Lists including Pulsenmore
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




